Boston Scientific’s Irish ops pulled down $1.4B last year | Wall Street Beat Wall Street Beat

Boston Scientific (NYSE:BSX) posted pre-tax profits of $1.4 billion from its Irish unit and other foreign subsidiaries last year, according to the Irish Times.

Marlborough, Mass.-based medical device company Boston Scientific is 1 of the Emerald Isle’s largest employers, with a 4,500-employee workforce there.

BSX’s Irish operations reported revenues of $5.37 billion for the 12 months ended Dec. 31, according to the newspaper, up 2% compared with 2011. The pre-tax profit increase represents 272% growth over the prior year, the Times reported.

Sign up to get our free newsletters delivered straight to your inbox

BSX logged a net loss of $725 million, or 52¢ per share, on sales of $1.74 billion for the 3 months ended Sept. 30. That represents a 7.4% top-line slide. Adjusted EPS were 16¢, just topping the 15¢ consensus on Wall Street.

 PE owner seeks $10B for Bausch & Lomb
The private equity owner of Bausch & Lomb is looking to sell the eye-care giant for $10 billion, according to BusinessWeek.

Warburg Pincus tapped Goldman Sachs to broker the deal, according to the magazine, citing "2 two people with knowledge of the matter."

Warburg Pincus bought the Rochester, N.Y.-based company for $3.7 billion in September 2007 after a damaging recall of 1 of its contact lens solutions.

Sanofi (NYSE:SNY), GlaxoSmithKline (NYSE:GSK) and Merck (NYSE:MRK) are said to be in the running, with others including Abbott (NYSE:ABT) waiting in the wings.

Rumors surfaced over the summer that Warburg might seek to take B&L public. That could still happen if a private buyer can’t be found, according to BusinessWeek.
Read more

 Harvard Bioscience gains 15% on subsidiary’s spinout
Harvard Bioscience shares are up more than 15% today after the company announced the planned spinout of its Harvard Apparatus Regenerative Technology unit.

HBIO shares were trading at $4.34 apiece as of about 1:50 p.m. today, up 14.6%.
Read more

 sBioMed seeks $5M in private placement

SBioMed, the sterilization product maker led by former Stryker CEO Stephen MacMillan, is seeking to raise $5 million in a private placement, MacMillan told in an email.

MacMillan said the placement includes "many" current investors and "strong interest" from other backers in the medical industry.

"The opportunities in front of us are almost endless, from both a product and market perspective, so a clear short-term goal is prioritizing sales and product development needs. The near-term sales opportunities are very large just within hospital and healthcare facilities generally, but we’re also seeing a big opportunity within pharmaceutical and clean room manufacturing, as Steriplex is stronger and much ‘greener’ and less toxic than currently available products. A sporicidal disinfectant without [volatile organic compounds] is a clear winner," he told us.

 Funding Roundup

 Analysts’ ups and downs

  • Abbott (NYSE:ABT): JP Morgan reiterates “neutral” rating, $72 price target; Morgan Stanley reiterates "equal-weight" rating.
  • Align Technology (NSDQ:ALGN): Goldman Sachs initiates coverage at “neutral” rating, $28 price target.
  • Baxter (NYSE:BAX): Leerink Swann reiterates "outperform" rating, $74 price target.
  • Cynosure (NSDQ:CYNO): Leerink Swann maintains "outperform" rating, $31 price target.
  • Edwards Lifesciences (NYSE:EW): Leerink Swann reiterates “outperform” rating, $100 price target.
  • Hill-Rom (NYSE:HRC): Goldman Sachs upgrades from “neutral” to “buy” rating, raises price target from $30 to $39.
  • Hospira (NYSE:HSP): Goldman Sachs downgrades from “neutral” to “sell” rating.
  • Intuitive Surgical (NSDQ:ISRG): Cantor Fitzgerald maintains “hold” rating, raises price target from $475 to $525.
  • NuVasive Inc. (NSDQ:NUVA): Leerink Swann maintains "market perform" rating, $16 price target.
  • Smith & Nephew (FTSE:SN, NYSE:SNN): Investec raises from “hold” to “buy” rating.
  • Spectranetics (NSDQ:SPNC): Benchmark Co. reiterates "buy" rating, $7 price target.
  • Stryker (NYSE:SYK): Bank of America Merrill Lynch reiterates "buy" rating, raises price target from $57 to $67; Goldman Sachs raises from "neutral" to "buy" rating, raises price target from $55 to $68.
  • Teleflex (NYSE:TFX): Leerink Swann maintains "market perform" rating, ~$72 price target.
  • Varian Medical (NYSE:VAR): Cantor Fitzgerald reiterates "hold" rating, raises price target from $63 to $70.
  • Volcano (NSDQ:VOLC): Credit Suisse Group downgrades from "outperform" to "neutral" rating, lowers price target from $32 to $27; Leerink Swann reiterates "outperform" rating, $32 price target.
  • Zimmer (NYSE:ZMH): Goldman Sachs upgrades from “sell” to “neutral” rating, raises price target from $58 to $70.

RSS From Medical Design & Outsourcing

  • Molex delivers ISO 13485-compliant, medical-grade surgical cables from its class 100,000 clean room facility
    Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in Thailand, the facility has less than 100,000 particulates (≥0.5µm) per cubic foot of air and manufactures a variety of ISO 13485-compliant medical cables and surgical cables used in operating theatres, hospitals, laboratories and […]
  • Swept-Source OCT: Patent license agreement between Massachusetts General Hospital and Heidelberg Engineering
    Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and […]
  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]
  • First ‘Ear Wear’ for Active Adults Debuts with MDHearingAid FIT
    If you’ve burned out your ears with earbuds, headphones or decades of other audio abuse but aren’t ready for your grandmother’s hearing aids, not to worry! The new MDHearingAid FIT gets you back in the game with a tiny, FDA-registered, one-size-fits-most solution that doesn’t block your ear canal like old-fashioned in-the-ear hearing aids. The FIT feels […]
  • CardioGenics enters into manufacturing agreement with Ontario-based Plasticap
    CardioGenics Holdings, developer for the In-Vitro-Diagnostics (“IVD”) testing market, announced that it has entered into a manufacturing agreement with Plasticap of Ontario, Canada, pursuant to which Plasticap will manufacture CardioGenics’ proprietary self-metering cartridges for its QL Care analyzer. The term of the agreement is three years and the purchase price for each cartridge shall be […]
  • MTD Micro Molding releases micro materials menu
    MTD Micro Molding, a long-time leader in micro-injection molding, has released an updated “Materials Menu” of materials that can be successfully micromolded to help guide engineers at medical device companies. Material selection is a crucial step in product manufacturability. The correct material drives tolerance, dimension, strength, usabality, speed-to-market, design, critical features, and cost. Through MTD’s […]
  • MedTech Chat: Elastic technology for drug delivery
    Dr. Zhen Gu and Dr. Yong Zhu from North Carolina State University are both co-senior authors of a research paper describing their recent work. Dr. Gu, Dr. Zhu and other researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a drug delivery technology that consists of an […]
  • B. Braun’s OEM Division offers large bore normally closed low-pressure check valves
    Infusion therapy and pain management device manufacturer B. Braun said today it is offering normally closed large-bore low-pressure check valves through its valve-focused contract manufacturing OEM division. The valves, offered by Bethlehem, Pa.-based B. Braun, are designed for the intermittent injection of fluids during medical treatment and open automatically when pressure is applied. The newly […]

Leave a Reply